Cytori Therapeutics CEO Marc Hedrick's 2021 pay jumps 47% to $1.7M
Cytori Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 7, 2022
Cytori Therapeutics reported fiscal year 2021 executive compensation information on April 7, 2022.
In 2021, three executives at Cytori Therapeutics received on average a compensation package of $935K, a 21% increase compared to previous year.
Average pay of disclosed executives at Cytori Therapeutics
Marc H. Hedrick, Chief Executive Officer, received $1.7M in total, which increased by 47% compared to 2020. 46% of Hedrick's compensation, or $773K, was in option awards. Hedrick also received $365K in non-equity incentive plan, $510K in salary, as well as $19K in other compensation.
Andrew Sims, Chief Financial Officer, received a compensation package of $845K, which increased by 105% compared to previous year. 55% of the compensation package, or $468K, was in option awards.
Norman LaFrance, Chief Medical Officer, earned $293K in 2021.
Related executives
You may also like
Source: SEC filing on April 7, 2022.